Journals on Medical Drug and Therapeutics - BJSTR Journal

Abstract

#Insulin access has been challenging for many patients as the insulin price has been nearly tripled between 2002 to 2013. The ADA released a white paper on insulin access and affordability and the authors concluded that there is a lack of transparency in the insulin supply chain and patients with #diabetes are financially harmed with increasing insulin prices and prescribing patterns favored more expensive insulin analogs. The ADA recommended healthcare providers including pharmacists should educate patients about the cost of insulin, pros, cons and its financial implications. #Pharmacists are uniquely situated in community, ambulatory care and institutional settings to guide patients and other healthcare providers on various resources available for patients with diabetes to obtain insulin at no cost to reduced cost based on patient's health plan, income level and #Medicare Part D coverage gap and uninsured patients. Majority of these resources are web-based and available for both patients and other healthcare providers by a click of a button. Educating patients with diabetes about various options to obtain insulin with the lowest price possible is only a short-term solution.

For more articles on BJSTR Journal please click on https://biomedres.us/

For more Medical Drug and Therapeutics Articles on BJSTR

https://biomedres.us/fulltexts/BJSTR.MS.ID.001633.php

Increasing Insulin Prices - Role of Pharmacists in Assisting Patients with Diabetes to Enhance Access by Hyma P Gogineni in BJSTR